CareTrust REIT, Inc. (CTRE) — Fair Value Analysis

Base-case fair value (P50): $33.04 · Current price: $38.77 · Verdict: Fairly Valued

The Verdict on CTRE

Our Monte Carlo simulations indicate that CARETRUST REIT INC (CTRE) is Deeply Overvalued at its current market price. With CTRE trading at $38.77, our median fair value (P50) stands significantly lower at $33.04. This stark difference implies a projected -14.8% downside from the current trading level, suggesting considerable risk for investors at this valuation. The quantitative models, running thousands of forward scenarios, consistently point to a considerable disconnect between CTRE's market price and its intrinsic value based on our comprehensive analysis.

How CTRE stacks up against peers

While CTRE's quality tier is currently unrated, which means its operational and financial health relative to its sector is not yet formally assessed, the valuation discrepancy remains prominent. The $38.77 currently reflects a premium over our $33.04 Monte Carlo-derived fair value. This premium is not necessarily justified by a clear operational advantage given its unrated status, making the -14.8% gap a critical factor for consideration. Without a defined quality rating, investors lack a clear signal of superior fundamentals that might otherwise support such an elevated market price against its calculated fair value.

What this means for investors

Investors eyeing CTRE should exercise extreme caution given the Deeply Overvalued verdict. The current price of $38.77 deviates substantially from the $33.04 fair value, presenting a -14.8% potential downside according to our probabilistic models. This suggests the market is pricing in expectations that exceed the most probable outcomes generated by our simulations. Monitoring this gap will be crucial. For a complete picture of CTRE’s fair value distribution, including bear and bull cases and the probability of upside scenarios, sign up for a free FairCurve account.